Cancer Drug with Better Staying Power and Reduced Toxicity Shows Preclinical Promise

March 16, 2020 • by Marc Airhart

The texaphyrin molecule is designed to be more easily absorbed by cancerous cells than healthy human cells, reducing the drug’s side effects.

The drug candidate, called OxaliTEX, is made of two parts.

The drug candidate, called OxaliTEX, is made of two parts: a star-shaped molecule (blue) called texaphyrin that acts like a kind of delivery truck and a modified version of a platinum drug (red) that acts like a toxic package for cancer cells. Illustration credit: iQ Group Global.


Share